~" Detailed preoperative electroencephalographic (EEG) studies are now recommended for children with seizures and cortical tumors to define seizure foci prior to surgery. To develop a historical perspective for better evaluation of results from series reporting tumor removal combined with resection of seizure foci, the authors reviewed seizure outcome in 60 children with seizures and low-grade neoplasms treated consecutively since 1981 by surgical resection without concomitant EEG monitoring or electrocortical mapping. Forty-seven of the 60 tumors were totally or near-totally resected; 45 patients were seizure-free and two were significantly improved 1 year following surgery. Of the 50 children in this series with more than five seizures prior to surgery, 36 were seizure-free, two were significantly improved, and 12 were not improved. Factors associated with poor seizure control included a parietal tumor location, a partial tumor resection, and a history of seizures for more than 1 year prior to surgery. The children at highest risk for poor seizure control at 2 years had experienced seizures for more than 1 year prior to surgery and had undergone partial resection of their parietal low-grade glial tumors or gangliogliomas. In contradistinction, the best seizure control was seen in patients with totally resected low-grade gliomas or gangliogliomas who had experienced seizures for less than 1 year (concordance rates for being seizure-free ranged from 78% to 86%). Long-term seizure control remained excellent. These results suggest that seizure control can be obtained 2 years following tumor surgery in the majority of children with presumed tumors after extensive tumor resection without concomitant EEG monitoring or electrocortical mapping.
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low-grade glioma seizure seizure surgery 9 brain neoplasm 9 electroencephalography ganglioglioma 9 children NE percent of children will experience an afebrile seizure by 14 years of age, and between four and nine children per 100,00 at risk will develop recurrent afebrile seizures. 18 Virtually any insult to the developing nervous system can result in seizures. Although only a minority of children with epilepsy harbor an underlying central nervous system tumor, seizures are second only to headaches as the most common presenting symptom of cortical tumors in childhood. 6, 14, 15 Tumor-related seizures are more frequently associated with slow-growing, infiltrating neoplasms, and may be of any type.
The optimum treatment for low-grade neoplasms in children remains controversial; however, there is general consensus that, when feasible, gross total surgical resection is the treatment of choice. 11 The majority of children with cortical low-grade gliomas will be alive and free of progressive disease 5 years following gross total tumor resection, 11 but the seizure control in patients whose tumors have been resected is not well delineated. The form of epilepsy associated with slowgrowing tumors most likely has its origin in the tumorfree cortex adjacent to the neoplastic nidus. 9,1~ A possible inference of this is that, if detailed electroencephalographic (EEG) seizure mapping were used to delineate seizure foci in patients with a presumed neoplasm and seizures prior to surgery, resection could be directed at improving seizure outcome. Surgical resection based partially on the results of EEG mapping studies is postulated to improve seizure control in patients with tumors. 1 Although such an approach has been shown to result in good seizure control 2 years following surgery, it has not been determined whether similar control could have been obtained after attempts to totally resect the tumor, especially when tumor extent is determined by currently available neuroradiographic techniques.
In an attempt to develop a historical perspective to evaluate results from series reporting tumor removal combined with resection of seizure loci, we reviewed seizure outcome in 60 consecutive children with seizures and low-grade glial neoplasms who were treated since 1981 by surgical resection without concomitant EEG monitoring or mapping for surrounding seizure foci.
Clinical Material and Methods
The records of all patients less than 18 years of age treated at the Children's Hospital of Philadelphia and the Children's National Medical Center between January, 1981, and January, 1991, with histologically proven low-grade cerebral neoplasms were reviewed. To be eligible for inclusion in the study, patients must have had at least one seizure prior to surgery and have had an abnormality on computerized tomography (CT) or magnetic resonance (MR) imaging suggesting a neoplasm. Eligible patients were allowed to have one or more EEG recordings, but no detailed EEG mapping prior to surgery to remove the presumed tumor, The standard of the institutions was to attempt gross total resections when feasible, as it was believed that "aggressive" resection was more likely to lead to longer tumor control.
Sixty children meeting the study criteria were identified (Table 1) . Children evaluated in the study had been followed for a median of 5.5 years (range 2 to 12 years). The mean patient age was 10.6 years, ranging between 1 and 20 years at the time of surgical resection. Forty patients were evaluated preoperatively by MR imaging (with or without CT) and 20 by CT alone. Tumor location was arbitrarily designated to the region of the brain most involved on imaging. Patients whose tumors were believed to arise primarily from the diencephalon were excluded from study, even if the tumor extended into adjacent overlying cortex. Tumor types eligible for analysis included low-grade glioma, ganglioglioma, mixed low-grade glioma, xanthoastrocytoma, and intermediate-grade glioma. Patients who harbored tumors with malignant loci were ineligible for study. Seizure types were categorized as generalized (including absence or akinetic), partial, complex partial, or mixed.
The extent of surgical resection was determined by the operative notes and results of postsurgery neuroradiographic studies. Tumors were considered to be "totally resected" if the surgeon believed that all visible tumor had been removed and the postoperative CT scans and/or MR imaging (with and without enhancement) disclosed no evidence of residual mass disease. Tumors were considered to be partially or subtotally resected if the surgeon concluded that tumor had been left behind or if the postoperative MR image or CI' scan demonstrated residual disease. No patient in the series underwent biopsy. Six children received radiation therapy following surgery, three after total and three after partial resection. Classification of outcome in patients was based on the number of seizures reported during the 13th to the 24th month following the operation. Auras were not considered to be seizure breakthroughs. A three-tiered categorization was used, as outlined by Dodrill, et alJ The patient's seizure outcome was considered to be: seizure-free if the patient was entirely free of seizures other than auras; significantly improved if the patient had at least 75% fewer seizures than in the year prior to surgery; and not significantly improved if the patient had not shown at least a 75% decrease in the number of seizures or had the same number or more seizures compared to preoperatively.
Statistical Analysis
Overall outcome was determined for the entire patient population (Group A). In addition, a separate analysis was performed for patients who had five or more seizures prior to surgery (Group B). Thus, all patients who had relatively few seizures prior to surgery were excluded from this second analysis. All statistical computations for the analyses were performed using the SAS-PC package.* Initially, Mantel-Haenszel chi-squared analysis and Fisher's exact tests were performed to determine the impact of various factors on seizure control including patient age, tumor location, degree of resection, seizure type, seizure frequency, histological type of tumor, and duration of seizures prior to operation. Since this was a retrospective study, no attempt was made to correlate outcome with anticonvulsant drug use and type, either prior to surgery or 13 to 24 months following surgery. After individual factors were analyzed, a multivariate linear logistic regression analysis was undertaken to determine which factors were significant. In addition, analysis was undertaken to determine the adequacy of the logistic model by computing concordance (association of predicted probabilities and the observed response) for seizure control and the Hosmer-Lemeshow 12 ehi-squared test of goodness of fit.
Although not the major focus of the study, an attempt was made to analyze the longer-term outcome of patients. The frequency of late seizure relapse was determined, and late (after 24 months) seizure recurrence was related to tumor status and other factors.
Results

Overall Seizure Control at Year 2
Two years after tumor resection, 45 of the total 60 patients (Group A) were seizure-free and two were significantly improved. Before surgery, 50 patients had had multiple (five or more) seizures (Group B) and the remaining 10 had less than five seizures. Of the 50 Group B patients, 36 were seizure-free 13 to 24 months after surgery, two were significantly improved, and 12 were not significantly improved. Of the 10 children with few seizures prior to surgery, nine were seizurefree and one continued to have seizures postoperatively. Prior to surgery, 52 patients were receiving anticonvulsant medications; this consisted of monotherapy in 42 and two-drug therapy in 10. At the 2-year evaluation point, 33 patients were still taking anticonvulsant agents, including 21 who were considered to be seizure-free. All 21 patients who were seizure-free were receiving monotherapy.
Factors Related to Seizure Control at Year 2
Various factors were statistically related to outcome (Table 2 ). Aparietal tumor location was associated with poor seizure control for all patients (Group A) and for patients with greater than five seizures prior to tumor surgery (Group B). Partial tumor resection was significantly associated with poorer seizure control in both Groups A and B. A history of seizures longer than 1 year prior to surgery was significantly associated with poorer outcome in Group B patients. Other factors were not statistically associated with poor outcome, although * SAS/STAT User's Guide, Version 6, ed 4, Vol 2, 1990, obtained from SAS Institute, Inc., Cary, North Carolina (see pp 1071-1126). there was a trend for poor outcome in patients with focal seizures (p < 0.07), for those with daily, weekly, or monthly seizures, rather than less frequent seizures (p < 0.06), and in Group B patients with mixed gliomas (p < 0.07). Although tumor location and degree of resection were associated with each other, multivariate analysis showed that they were independently related to outcome. Statistical modeling was used to determine which constellation of factors would be most predictive of outcome. For patients in Group A, the child at highest risk (Table 3) for poor seizure control at 2 years had experienced seizures for longer than 1 year prior to surgery and had a partially resected parietal low-grade glial tumor or ganglioglioma. The multivariate model was less predictive when only Group B patients were considered (73.2% Group B vs. 85.6% Group A), but children with subtotally resected parietal tumors of any type who had experienced seizures for longer than 1 year were still most likely to have poor seizure control. In patients who had more than five seizures prior to surgery (Group B), a history of seizures for longer than 1 year was the most important predictor of outcome.
In contrast, the best seizure control at 13 to 24 months was seen in patients with totally resected lowgrade gliomas or gangliogliomas, who had experienced seizures for less than 1 year. Concordance rates for being seizure-free ranged between 78.3% and 85.6%, with no statistical association between tumor location and seizure occurrence ( Table 4 ). The HosmerLemeshow goodness-of-fit test was not significant in either group of patients (Group A, p = 0.71; Group B, p = 0.78), suggesting that the logistic models utilized to determine concordance of outcomes were valid.
Longer-Term Outcome
Two years following treatment, all but one patient were stable and free of progressive disease. At a median of 6 89 years following surgery, seven patients developed progressive disease, of whom four had undergone resection and three had an initial partial resection (two receiving radiation therapy after initial resection). Of these seven patients, four had not been significantly * Seizure-free patients: concordance rate for totally resected lowgrade gliornas or gangliogliomas with less than 1 year of seizures, improved at the 2-year evaluation point, one developed late seizures, and two remained seizure-free despite tumor progression.
Seizures recurred in three of the 45 patients who were seizure-free at 2 years. All three were receiving anticonvulsant drugs 2 years after surgery and one (as stated previously) had tumor progression following total resection. In these three patients the tumor was located in the temporal lobe and all had total resection. Histological analysis of the tumor revealed a ganglioglioma in two and xanthoastrocytoma in one. Of the six patients who had received radiotherapy following surgery, four had had no seizures at the 2-year point; all remained seizure-free at follow-up evaluation.
Discussion
The results of this study suggest that the majority of patients with low-grade gliomas and seizures at the time of diagnosis who undergo tumor resection will be seizure-free 2 years following surgery; 45 (75%) of the 60 patients in our series were seizure-free 2 years following surgery. This included a favorable outcome in 36 (72%) of 50 patients with more than five seizures prior to diagnosis. Relatively few patients who were seizure-free at the 2-year point later went on to develop seizures. The evaluation point for this study (13 to 24 months after surgery) was arbitrarily chosen to make it comparable to other studies evaluating seizure control after epilepsy surgery. 9 Seizures that occur in the first few months after surgery have not been found to be predictive of long-term seizure control and were not analyzed in this report. During the period reviewed, the surgical bias of our two institutions was to attempt to resect as much tumor as possible in children with presumed low-grade cerebral glioma. This approach, in the CT and MR imaging era, may have had a significant influence on the favorable outcome seen.
The rate of seizure control in other studies attempting to correlate treatment to seizure control for children with benign cerebral tumors has varied dramatically. 3,8,13,17 Seizure-free rates ranging between 21% and 87% have been reported without prior EEG mapping and removal of seizure loci. The efficacy of tumor resection for the control of seizures has been questioned, since, in most series reporting a favorable outcome, a significant proportion of children remained on an anticonvulsant regimen following seizure surgery. However, in these reports, as in our study, there had been no specific attempt to withdraw anticonvulsant drugs. It is unclear how many of the 23 patients followed at our institutions who were seizure-free and still receiving medication at the 2-year evaluation point could have been safely withdrawn from anticonvulsant therapy; in this retrospective review, the continued use of anticonvulsant drugs was at the discretion of the managing physician.
The results after removal of tumor and electroencephalographically mapped seizure loci have also been variable. 4, 7, 21 In possibly the largest experience of surgery undertaken to treat patients with medically refractory temporal lobe seizures, Rasmussen 16 reported on 176 patients with low-grade neoplasms (of which 141 were low-grade gliomas), who underwent presurgical EEG mapping. Sixty of these patients had seizures before 16 years of age, and 144 patients were alive, free of progressive disease, and had adequate follow-up in-formation for evaluation 2 years following surgery. Sixty-six (46%) of these 144 patients became and remained seizure-free, and 76% had a complete or nearly complete reduction of seizure frequency. In that study, seizure control was similar in patients with nontumorrelated intractable epilepsy. Thus, the results of Rasmussen's series disclose outcomes similar to our experience without EEG-based resection. Rasmussen's series spans 26 years, gathering patients between 1954 and 1980; the vast majority of patients were diagnosed prior to the CT era and all before MR imaging. Before CT and MR imaging were available, determination of the extent of surgical tumor resection was virtually impossible; even with MR imaging and CT, such assessments are still relatively arbitrary for infiltrating lesions, but are probably more accurate. With better determination of extent of the lesion by neuroimaging, seizure control may be even better after tumor mass surgery.
Using electrocortical mapping techniques in pediatric patients, Berger, et al., 1 initially reported that, of 14 children with seizures refractory to medical therapy treated by tumor removal combined with seizure focus resection, 13 were weaned or being tapered off anticonvulsant drugs at a mean of 43 months from surgery. In an update of this experience] they reported that all 13 patients aged less than 19 years at the time of surgery were seizure-free at a mean follow-up time of 56 months and 11 were off of antiepileptic drugs. The results of the Berger study cannot be directly compared to ours. All 13 patients reported were said to have intractable epilepsy, but no specific details were given to define this intractable group. In the 60 patients reported in our series, there was no attempt to include only intractable patients, as the primary goal of surgery was tumor removal. Fifty of the patients had multiple seizures prior to tumor removal. Other factors such as tumor location, medications, duration of seizures prior to surgery, and extent of resection are virtually impossible to compare across institutional experiences, but, as seen in our review, influence seizure control.
The results of our study of 60 patients do not address the question of whether resection of seizure foci outside the tumor area gives more effective control of epilepsy. However, this CT-and MR imaging-based series does suggest that the majority of patients with seizures and low-grade tumors will have good seizure control following tumor surgery. A subgroup of patients, primarily those with parietal masses amenable to only partial resection and who have a greater than 1-year history of seizures prior to diagnosis, is at a higher risk of having poor seizure control after tumor resection. Only one-quarter of this subgroup of patients were seizurefree, but it is not known whether more complete tumor removal or mapping and resection of adjacent epileptogenic cortex would have resulted in improved seizure control and acceptable surgery-related morbidity.
Electroencephalographic mapping studies are expensive and inconvenient to the patient. Depending on the type of EEG evaluation chosen, especially the use of subdural or depth electrodes, there may also be an as-R. J. Packer, et al.
sociated morbidity and even a small risk of mortality. ~,2o Similarly, the rationale to recommend intensive invasive electrocorticographic monitoring for all patients, especially for those with cortical tumors amenable to gross total resection and few seizures prior to diagnosis, is not well substantiated in the literature. It is also not yet clear whether functional cortical mapping will improve a surgeon's ability to resect a tumor located in an eloquent region of brain enough to change seizure outcome. In this series, more than 80% of children with totally resected low-grade gliomas or gangliogliomas and less than 1 year of seizures prior to surgery were seizure-flee 13 to 24 months after tumor resection. Prospective randomized trials are the only way to determine if seizure surgery is more effective in controlling seizures than tumor mass surgery in children with low-grade infiltrating gliomas, especially when pre-and postoperative extent of disease is evaluated by CT or MR imaging. Such a study might be best initially performed in those children at highest risk for continued seizures after "tumor" resection.
